Daniel Tan Shao Weng

39PUBLICATIONS
297CO-AUTHORS
Implementation science and evaluationMolecular targetsArtificial life and complex adaptive systemsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Oct 14, 2026
Leveraging Real-World Evidence to Drive Advances in Oncology Care in the Asia-Pacific Region: Recommendations From the Asia-Pacific Oncology Drug Development Consortium Working Group.

|Aug 11, 2026
Early EGFR Inhibition Triggers Actionable Tumor and Microenvironmental Remodeling in Lung Cancer.

|Aug 07, 2026
AI-based augmentation of oncology clinical trials.

|Jul 10, 2026
Rethinking Molecular Profiling after First-line Osimertinib.

|May 13, 2026
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial.

|Mar 26, 2026
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.

Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano

Pageof 7

Frequent Collaborators

8 joint publications

Anders Jacobsen Skanderup

6 joint publications

Aaron C Tan

5 joint publications

Benjamin J Solomon

4 joint publications

Wan-Teck Lim